Plasma levels of D-dimer and soluble fibrin polymer in patients with hepatocellular carcinoma: A possible predictor of tumor thrombosis

Thrombosis Research

Volumn 109, Issue 2-3, 2003, Pages 125-129

  Kim, Hyun Kyung ^a   Lee, Kyoung Rhan ^a   Yang, Jeon Ho ^a   Yoo, Sung Jae ^a   Lee, Sang Won ^a   Jang, Hyun Jung ^a   Park, Sang Jae ^a   Moon, Young Soo ^a   Park, Joong Won ^a   Kim, Chang Min ^a  

^a National Cancer Center   (South Korea)

Author keywords

D dimer; Hepatocellular carcinoma; Soluble fibrin polymer; Tumor thrombosis

Indexed keywords

BIOLOGICAL MARKER; D DIMER; FIBRIN; POLYMER; PROTEIN PRECURSOR; THROMBUS PRECURSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; ENZYME IMMUNOASSAY; FEMALE; HEPATIC VEIN; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PORTAL VEIN; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; SOLUBILITY; THROMBOGENICITY; TUMOR THROMBUS;

BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; FEMALE; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEPATIC VEIN THROMBOSIS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 12444330873     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(03)00183-X     Document Type: Article

References (26)

1. Slichter S.J., Harker L.A. Haemostasis in malignancy. Ann. NY Acad. Sci. 230:1974;252-261.
2. Bromberg M.E., Cappello M. Cancer and blood coagulation: molecular aspects. Cancer J. Sci. Am. 5:1999;132-138.
3. Simpson-Haidaris P.J., Rybarczyk B. Tumor and fibrinogen: the role of fibrinogen as an extracellular matrix protein. Ann. NY Acad. Sci. 936:2001;406-425.
4. Shoji M., Hancock W.W., Abe K., Micko C., Casper K.A., Baine R.M.et al. Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am. J. Pathol. 152:1998;399-411.
5. Dvorak H.F. Tumors: wounds that do not heal. N. Engl. J. Med. 315:1986;1650-1659.
6. Gunji Y., Gorelik E. Role of fibrin coagulation in protection of murine tumor cells from destruction by cytotoxic cells. Cancer Res. 1988;485216-485221.
7. Gaffney P.J. The occurrence and clinical relevance of fibrin fragments in blood. Ann. NY Acad. Sci. 408:1983;407-423.
8. Carville D.G.M., Dimitrijevic N., Walsh M., Digirolamo T., Brill E.M., Drew N.et al. Thrombus precursor protein (TpP™): marker of thrombosis early in the pathogenesis of myocardial infarction. Clin. Chem. 42:1996;1537-1541.
9. Laurino J.P., Pelletier T.E., Eadry R., Kounavis A. Thrombus Precursor Protein™ and the measurement of thrombosis in patients with acute chest pain syndrome. Ann. Clin. Lab. Sci. 27:1997;338-345.
10. Iwatsuki S., Dvorchik I., Marsh J.W., Madariaga J.R., Carr B., Fung J.J.et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J. Am. Coll. Surg. 191:2000;389-394.
11. Oya M., Akiyama Y., Yanagida T., Akao S., Ishikawa H. Plasma D-dimer level in patients with colorectal cancer: its role as a tumor marker. Surg. Today. 28:1998;373-378.
12. den Ouden M., Ubachs J.M.H., Stoot J.E.G.M., van Wersch J.W.J. Thrombin-antithrombin III and D-dimer plasma levels in patients with benign or malignant ovarian tumours. Scand. J. Clin. Lab. Invest. 58:1998;555-560.
13. Taguch O., Gabazza E.C., Yasui H., Kobayashi T., Yoshida M., Kobayashi H. Prognostic significance of plasma D-dimer levels in patients with lung cancer. Thorax. 52:1997;563-565.
14. Dirix L.Y., Salgado R., Weytjens R., Colpaert C., Benoy I., Huget P.et al. Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer. Br. J. Cancer. 86:2002;389-395.
15. Gadducci A., Marrai R., Baicchi U., Gagetti O., Facchini V., Genazzani A.R. Prothrombin fragment F1.2 and thrombin-antithrombin III complex (TAT) plasma levels in patients with gynecological cancer. Gynecol. Oncol. 61:1996;215-217.
16. Levine M.N., Gent M., Hirsh J., Arnold A., Goodyear M.D., Htyniuk W.et al. The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. N. Engl. J. Med. 318:1988;404-407.
17. AJCC cancer staging manual. 1997;Lippincott Williams and Wilkins, Philadelphia.
18. Kohli M., Fink L.M., Spencer H.J., Zent C.S. Advanced prostate cancer activates coagulation: a controlled study of activation markers of coagulation in ambulatory patients with localized and advanced prostate cancer. Blood Coagul. Fibrinolysis. 13:2002;1-5.
19. Tempelhoff G.F., Dietrich M., Hommel G., Heilmann L. Blood coagulation during adjuvant epirubicin/cyclophosphamide chemotherapy in patients with primary operable breast cancer. J. Clin. Oncol. 14:1996;2560-2568.
20. Denko N.C., Giaccia A.J. Tumor hypoxia, the physiological link between Trousseau's syndrome (carcinoma-induced coagulopathy) and metastasis. Cancer Res. 61:2001;795-798.
21. Pieper C.F., Rao K.M., Currie M.S., Harris T.B., Cohen H.J. Age, functional status, and racial differences in plasma D-dimer levels in community-dwelling elderly persons. J. Gerontol. 55:2000;M649-M657.
22. Hettasch J.M., Greenberg C.S. Fibrin formation and stabilization. Loscalzo J., Schafer A.I. Thrombosis and hemorrhage. 1998;129-154 Williams and Wilkins, Baltimore.
23. Arkel Y.S., Ku D.H.W., Le P., Carr A.M. Comparison of a test for soluble fibrin polymer (TpP™) with a standard quantitative ELISA for D-dimer in patients, without current thrombosis, who have cancer or renal disease. Thromb. Haemost. 86:2001;1127-1128.
24. Mitsunobu M., Toyosaka A., Oriyama T., Okamoto E., Nakao N. Intrahepatic metastasis in hepatocellular carcinoma: the role of the portal vein as an efferent vessel. Clin. Exp. Metastasis. 14:1996;520-529.
25. Cedrone A., Rapaccini G.L., Pompili M., Aliotta A., Trombino C., De L.F.et al. Portal vein thrombosis complicating hepatocellular carcinoma. Value of ultrasound-guided fine-needle biopsy of the thrombus in the therapeutic management. Liver. 16:1996;94-98.
26. Blackwell K., Harron Z., Broadwater G., Berry D., Harris L., Iglehart J.D.et al. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status. J. Clin. Oncol. 18:2000;600-608.